|
|
|
Insider
Information: |
Myles Edward H |
Relationship: |
|
City: |
Swansea |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
302,177 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,099,692 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
302,177 |
|
|
Total
Value |
$3,099,692 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-300.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pressure Biosciences Inc |
PBIO |
VP of Finance & CFO |
2006-09-07 |
2,000 |
2006-08-28 |
0 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
COO & CFO |
2020-03-10 |
98,659 |
2016-04-11 |
0 |
Premium* |
|
Scholar Rock Holding Corp |
SRRK |
|
2024-06-17 |
201,518 |
2021-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMAG |
AMAG Pharmaceuticals Inc |
Chief Financial Officer |
|
2018-03-02 |
4 |
D |
$21.00 |
$17,934 |
D/D |
(854) |
53,294 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
COO & CFO |
|
2020-02-23 |
4 |
D |
$9.50 |
$8,237 |
D/D |
(867) |
78,566 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-02-23 |
4 |
D |
$15.51 |
$13,478 |
D/D |
(869) |
50,461 |
0 |
- |
|
PBIO |
Pressure Biosciences Inc |
VP of Finance & CFO |
|
2006-08-28 |
4 |
B |
$3.00 |
$3,000 |
D/D |
1,000 |
0 |
2.66 |
- |
|
PBIO |
Pressure Biosciences Inc |
VP of Finance & CFO |
|
2006-09-07 |
4 |
B |
$3.00 |
$3,000 |
D/D |
1,000 |
2,000 |
2.66 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
COO & CFO |
|
2020-03-02 |
4 |
D |
$7.75 |
$7,913 |
D/D |
(1,021) |
68,659 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-03-02 |
4 |
D |
$14.76 |
$15,705 |
D/D |
(1,064) |
81,397 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
COO & CFO |
|
2020-02-25 |
4 |
D |
$8.84 |
$12,252 |
D/D |
(1,386) |
77,180 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Financial Officer |
|
2018-07-02 |
4 |
D |
$19.85 |
$38,985 |
D/D |
(1,964) |
51,330 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-04-11 |
4 |
D |
$12.47 |
$24,491 |
D/D |
(1,964) |
79,433 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Financial Officer |
|
2017-05-08 |
4 |
D |
$18.55 |
$40,383 |
D/D |
(2,177) |
32,823 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2022-01-18 |
4 |
D |
$19.46 |
$42,390 |
D/D |
(2,178) |
21,972 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2024-02-16 |
4 |
S |
$15.74 |
$74,686 |
D/D |
(4,744) |
210,976 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2021-11-15 |
4 |
AS |
$35.05 |
$171,006 |
D/D |
(4,879) |
24,150 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2021-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,879 |
29,029 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2024-01-16 |
4 |
S |
$15.93 |
$105,670 |
D/D |
(6,634) |
162,150 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-01-17 |
4 |
D |
$11.29 |
$79,503 |
D/D |
(7,043) |
147,179 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-06-21 |
4 |
D |
$8.75 |
$62,456 |
D/D |
(7,138) |
203,791 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2024-06-17 |
4 |
S |
$8.98 |
$84,978 |
D/D |
(9,458) |
201,518 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-12-29 |
4 |
AS |
$18.82 |
$234,633 |
D/D |
(12,459) |
168,784 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-12-29 |
4 |
OE |
$4.86 |
$60,551 |
D/D |
12,459 |
181,243 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Financial Officer |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
35,000 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Financial Officer |
|
2016-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Financial Officer |
|
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
54,148 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2021-11-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,574 |
47,724 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|